Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog

被引:72
作者
Chu, Q
Lopez, M
Hayashi, K
Ionescu, M
Billinghurst, RC
Johnson, KA
Poole, AR
Markel, MD
机构
[1] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Comparat Orthopaed Res Lab, Madison, WI 53706 USA
[2] McGill Univ, Shriners Hosp Children, Joint Dis Lab, Dept Surg, Montreal, PQ, Canada
[3] McGill Univ, Shriners Hosp Children, Joint Dis Lab, Dept Med, Montreal, PQ, Canada
[4] Ohio State Univ, Dept Vet Clin Sci, Columbus, OH 43210 USA
关键词
COL2-3/4; long; 3B3(-); osteoarthritis; monopolar radiofrequency energy; knee; canine; cranial cruciate ligament;
D O I
10.1053/joca.2002.0812
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Clinical relevance: Measurement of markers of cartilage pathology in synovial fluid may provide clinical rheumatologists and osteoarthritis (CA) researchers important information for early diagnosis of OA as well as a method for monitoring disease progression and response to treatment. This study demonstrates the value of this approach in an established model of CA (cranial cruciate ligament rupture) at a point distant enough from the original surgical manipulation so as to have little to no effect on the marker concentrations. Objective: The objective of this study was to determine whether measurement of markers of cartilage collagen cleavage and proteoglycan turnover in synovial fluid from a canine model could be used to detect cartilage changes following the onset of joint instability during the development of OA. Design: A model of joint instability that develops CA was created in 18 mature dogs using monopolar radiofrequency energy (MRFE). MRFE was arthroscopically applied to one cranial cruciate ligament (CCL) while the contralateral CCL was sham treated. The treated CCLs ruptured approximately 8 weeks (55 +/- 1.6 days) after MRFE treatment. Synovial fluid was collected at time zero prior to MRFE treatment, 4 weeks after MRFE treatment, and at 4, 8, and 16 weeks after CCL rupture. Synovial fluid concentrations of the neoepitope COL2-3/4C long (type 11 collagen cleavage by collagenase) and epitopes 3B3(-) (proteoglycan aggrecan sulfation) and 846 (associated with aggrecan synthesis) were analyzed. Results: Compared to sham treated joints, the synovial fluid concentrations of COL2-3/4C long and 3B3(-) were significantly increased 2.2 fold and 2.9 fold, respectively, in joints with MRFE treated CCLs following CCL rupture. Concentrations of the 846 epitope in synovial fluid showed a trend toward an increase, which was not significant, after CCL rupture. Conclusions: Concentrations of the collagenase-cleaved type 11 collagen neoepitope and 3B3(-) epitope in synovial fluid were significantly increased by 4 weeks and remained elevated for at least 16 weeks after CCL rupture. This suggests that in dogs the COL2-3/4C long neoepitope and 3B3(-) epitope are sensitive markers for changes in joint cartilage turnover in joints that are developing CA. (C) 2002 OsteoArthritis Research Society International. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:662 / 669
页数:8
相关论文
共 36 条
[1]   Synovial fluid chondroitin sulphate epitopes 3B3 and 7D4, and glycosaminoglycan in human knee osteoarthritis after exercise [J].
Bautch, JC ;
Clayton, MK ;
Chu, QL ;
Johnson, KA .
ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 (11) :887-891
[2]   Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage [J].
Billinghurst, RC ;
Dahlberg, L ;
Ionescu, M ;
Reiner, A ;
Bourne, R ;
Rorabeck, C ;
Mitchell, P ;
Hambor, J ;
Diekmann, O ;
Tschesche, H ;
Chen, J ;
VanWart, H ;
Poole, AR .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1534-1545
[3]   OSTEOARTHRITIS IN CYNOMOLGUS MACAQUES .2. DETECTION OF MODULATED PROTEOGLYCAN EPITOPES IN CARTILAGE AND SYNOVIAL-FLUID [J].
CARLSON, CS ;
LOESER, RF ;
JOHNSTONE, B ;
TULLI, HM ;
DOBSON, DB ;
CATERSON, B .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1995, 13 (03) :399-409
[4]  
CATERSON B, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P415
[5]   Anabolic and catabolic markers of proteoglycan metabolism in osteoarthritis [J].
Caterson, B ;
Hughes, CE ;
Roughley, P ;
Mort, JS .
ACTA ORTHOPAEDICA SCANDINAVICA, 1995, 66 :121-124
[6]   IMMUNOHISTOCHEMICAL DETECTION AND IMMUNOCHEMICAL ANALYSIS OF TYPE-II COLLAGEN DEGRADATION IN HUMAN NORMAL, RHEUMATOID, AND OSTEOARTHRITIC ARTICULAR CARTILAGES AND IN EXPLANTS OF BOVINE ARTICULAR-CARTILAGE CULTURED WITH INTERLEUKIN-1 [J].
DODGE, GR ;
POOLE, AR .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (02) :647-661
[7]  
Fernandes JC, 1998, J RHEUMATOL, V25, P1585
[8]  
Frisbie DD, 1999, AM J VET RES, V60, P306
[9]   AGE-RELATED-CHANGES IN PROTEIN-RELATED EPITOPES OF HUMAN ARTICULAR-CARTILAGE PROTEOGLYCANS [J].
GLANT, TT ;
MIKECZ, K ;
ROUGHLEY, PJ ;
BUZAS, E ;
POOLE, AR .
BIOCHEMICAL JOURNAL, 1986, 236 (01) :71-75
[10]  
Hay CW, 1997, AM J VET RES, V58, P1027